Publications by authors named "W H PROCTOR"

Claim this Profile
C
Contemporary perspective and practical application of glutamate dehydrogenase in nonclinical studies.
Ravindra C Kodihalli, Mehrdad Ameri, Kevin S Baker, Samantha C Faber, Armando R Irizarry Rovira, William R Proctor

Biomark Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industry Perspective on Nonclinical Approaches for Hepatotoxicity Risk Assessment: Insights from Two Longitudinal Surveys Conducted in 2023 and 2017.
Melanie Z Sakatis, Leah M Norona, Jamie E Karmel, William R Proctor, Fatou H Sarr

Chem Res Toxicol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider.
Lise I Loberg, William R Proctor, Andrew D Burdick, Annick Cauvin, Anthony M DeLise

Regul Toxicol Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors.
Yogesh K Chutake, Michele F Mayo, Nancy Dumont, Jessica Filiatrault, Susanne B Breitkopf, William R Proctor

Mol Cancer Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
Szczepan W Baran, Paul C Brown, Andreas R Baudy, Suzanne C Fitzpatrick, Christopher Frantz, William R Proctor

ALTEX· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis